发布求助
文献互助 智能选刊 最新文献

PharmacoEconomics & Outcomes News最新文献

筛选
英文 中文
FreeStyle Libre Flash cost effective for glucose monitoring FreeStyle Libre Flash成本有效的葡萄糖监测
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08170-8
{"title":"FreeStyle Libre Flash cost effective for glucose monitoring","authors":"","doi":"10.1007/s40274-021-08170-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08170-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"29 2 1","pages":"12 - 12"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85478336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No benefit of peritoneal dialysis over haemodialysis for uninsured ESKD patients in the USA 在美国，腹膜透析比血液透析对未投保的ESKD患者没有好处
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08177-8
{"title":"No benefit of peritoneal dialysis over haemodialysis for uninsured ESKD patients in the USA","authors":"","doi":"10.1007/s40274-021-08177-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08177-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"4 1","pages":"19 - 19"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78569887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
More invasive prophylactic strategies worth it for BRCA1/2 mutation-positive women BRCA1/2突变阳性女性更有价值的侵入性预防策略
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08211-z
{"title":"More invasive prophylactic strategies worth it for BRCA1/2 mutation-positive women","authors":"","doi":"10.1007/s40274-021-08211-z","DOIUrl":"https://doi.org/10.1007/s40274-021-08211-z","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"52 1","pages":"16 - 16"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91265203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute care costs of neonatal sepsis and meningitis in Africa 非洲新生儿败血症和脑膜炎的急性护理费用
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08160-9
{"title":"Acute care costs of neonatal sepsis and meningitis in Africa","authors":"","doi":"10.1007/s40274-021-08160-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08160-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"37 1","pages":"2 - 2"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87404188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New ICER report shows highest US drug price increases not backed by clinical evidence ICER的新报告显示，美国药品价格涨幅最高，没有临床证据支持
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08228-y
{"title":"New ICER report shows highest US drug price increases not backed by clinical evidence","authors":"","doi":"10.1007/s40274-021-08228-y","DOIUrl":"https://doi.org/10.1007/s40274-021-08228-y","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"52 1","pages":"33 - 33"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81038919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catastrophic out-of-pocket costs for around 10% of Medicare FFS patients with HF in the USA 美国约10%的联邦医疗保险FFS心衰患者的灾难性自付费用
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08202-0
{"title":"Catastrophic out-of-pocket costs for around 10% of Medicare FFS patients with HF in the USA","authors":"","doi":"10.1007/s40274-021-08202-0","DOIUrl":"https://doi.org/10.1007/s40274-021-08202-0","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"35 1","pages":"7 - 7"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83241535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insulin glargine/lixisenatide good value in type 2 diabetes 甘精胰岛素/利昔那肽在2型糖尿病中的良好价值
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08173-8
{"title":"Insulin glargine/lixisenatide good value in type 2 diabetes","authors":"","doi":"10.1007/s40274-021-08173-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08173-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"1 1","pages":"15 - 15"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83289558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PCSK9 inhibitors not cost effective versus other antihyperlipidaemics PCSK9抑制剂与其他抗高脂血症药物相比没有成本效益
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08179-8
{"title":"PCSK9 inhibitors not cost effective versus other antihyperlipidaemics","authors":"","doi":"10.1007/s40274-021-08179-8","DOIUrl":"https://doi.org/10.1007/s40274-021-08179-8","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"110 1","pages":"21 - 21"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83448445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous monitoring technology improves outcomes and reduce costs in acute-care setting 持续监测技术改善了急性护理环境的结果并降低了成本
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08163-9
{"title":"Continuous monitoring technology improves outcomes and reduce costs in acute-care setting","authors":"","doi":"10.1007/s40274-021-08163-9","DOIUrl":"https://doi.org/10.1007/s40274-021-08163-9","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"245 1","pages":"5 - 5"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72662780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Originator-to-biosimilar non-medical switch may not yield such great cost savings 从原料药到生物仿制药的非医疗转换可能不会产生如此巨大的成本节约
PharmacoEconomics & Outcomes News Pub Date : 2021-11-01 DOI: 10.1007/s40274-021-08212-z
{"title":"Originator-to-biosimilar non-medical switch may not yield such great cost savings","authors":"","doi":"10.1007/s40274-021-08212-z","DOIUrl":"https://doi.org/10.1007/s40274-021-08212-z","url":null,"abstract":"","PeriodicalId":19781,"journal":{"name":"PharmacoEconomics & Outcomes News","volume":"44 1","pages":"17 - 17"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77550947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信